Stocks and Investing Stocks and Investing
Wed, April 6, 2022

Mani Foroohar Maintained (BLUE) at Hold with Decreased Target to $8 on, Apr 6th, 2022


Published on 2024-10-27 20:19:22 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $10 to $8 on, Apr 6th, 2022.

Mani has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Tuesday, March 8th, 2022


These are the ratings of the 2 analyists that currently disagree with Mani


  • Gena Wang of "Barclays" Downgraded from Hold to Sell and Decreased Target to $4 on, Monday, March 7th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $5 on, Monday, March 7th, 2022
Contributing Sources